Assessment of compliance with lipid guidelines in an academic medical center

Area of Science:

• Cardiology
• Vascular Medicine
• Pharmacotherapy

Background:

• Established guidelines recommend low-density lipoprotein cholesterol (LDL-C) < 100 mg/dL for patients with coronary artery disease (CAD) or cerebrovascular disease (CVD).
• Secondary lipid goals include high-density lipoprotein cholesterol (HDL-C) > 40 mg/dL and triglycerides < 150 mg/dL.
• Optimizing lipid levels is crucial for managing cardiovascular risk in these patient populations.

Purpose of the Study:

• To assess the achievement of primary (LDL-C) and secondary (HDL-C, triglycerides) lipid goals in hospitalized patients with established CAD or CVD.
• To evaluate adherence to American Heart Association (AHA)/American College of Cardiology (ACC) lipid management guidelines within an academic inpatient setting.

Main Methods:

• Retrospective chart review of patients discharged with diagnoses of acute myocardial infarction, myocardial revascularization, or ischemic stroke.
• Assessment of lipid panel testing frequency and achievement of target lipid levels (LDL-C, HDL-C, triglycerides).
• Evaluation of lipid-lowering medication prescriptions at discharge.

Main Results:

• Only 63% of patients had a lipid panel assessed during hospitalization.
• Less than half (40%) of patients with tested lipid panels achieved the LDL-C goal (< 100 mg/dL).
• Fewer patients met both primary and secondary lipid goals (24%), and a significant number were not prescribed appropriate lipid-lowering therapy at discharge.

Conclusions:

• A low proportion of patients with CAD or CVD achieved recommended lipid management goals during inpatient care.
• Discharge prescribing patterns for lipid-lowering therapy were suboptimal, despite established guidelines.
• Increased awareness and improved adherence to lipid management protocols are necessary to optimize cardiovascular outcomes.